Physician profile
Steven Joe Kin
NPI 1427037282
$16,004.89
in general payments reported to CMS, 2019-2025
27 companies · $2,456 in 2025
The $2,456 reported for 2025 was more than what 85% of Otolaryngic Allergy providers received nationally (typical 2025 total: $449).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,170 · 2020: $1,482 · 2021: $1,246 · 2022: $3,854 · 2023: $1,873 · 2024: $2,925 · 2025: $2,456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,148 · Travel and Lodging: $952 · Consulting Fee: $135 · Education: $17.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,148.30 |
| Travel and Lodging | $952.33 |
| Consulting Fee | $135.00 |
| Education | $17.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,718.39 | 2019-2025 | Scopis Ent, Xpress Loprofile, Xpress Ent Dilation System |
| Acelrx Pharmaceuticals, INC. | $2,267.24 | 2021-2022 | |
| Medtronic, INC. | $1,599.14 | 2023-2025 | Propel, Stealthstation S8 Platform, Nim Vital |
| Integra Lifesciences Corporation | $1,583.86 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Acclarent, INC | $1,509.33 | 2019-2024 | Acclarent Navwire, Relieva Spinplus |
| Regeneron Healthcare Solutions, INC. | $857.28 | 2019-2025 | Dupixent |
| Glaxosmithkline, LLC. | $833.26 | 2021-2025 | Nucala |
| Intersect Ent, INC. | $673.50 | 2019-2021 | |
| Alk-Abello, INC | $393.72 | 2019-2025 | Pre-Pen, Alternaria Tenuis, Timothy, Standardized |
| Acera Surgical, INC. | $304.15 | 2023-2025 | Restrata Wound Matrix |
| Genzyme Corporation | $286.50 | 2021-2024 | |
| Optinose US, INC. | $266.17 | 2019-2022 | |
| Aerin Medical INC. | $265.24 | 2019 | |
| Intuitive Surgical, INC. | $225.52 | 2022 | |
| Medtronic USA, INC. | $225.04 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Checkpoint Surgical, INC | $182.60 | 2021-2022 | |
| Hologic Sales and Service, LLC | $156.67 | 2023-2025 | Coolseal Generator |
| Smith+Nephew, INC. | $149.29 | 2024 | Grafix Pl |
| Becton, Dickinson and Company | $142.99 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $120.04 | 2025 | Neffy |
| Ambu INC. | $117.42 | 2022 | |
| Biocryst US Sales Co., LLC | $28.90 | 2025 | Orladeyo |
| Takeda Pharmaceuticals U.S.A., INC. | $22.81 | 2024 | Takhzyro |
| Hikma Pharmaceuticals USA | $22.78 | 2023 | Ryaltris |
| Paratek Pharmaceuticals, INC. | $19.56 | 2025 | Xhance |
| Pfizer INC. | $17.24 | 2019 | |
| Merck Sharp & Dohme LLC | $16.25 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Kin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.